Skip to Content
  1. All products
  2. Weight Management
  3. Tesamorelin / Ipamorelin
  4. Weight Management
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
Tesamorelin / Ipamorelin

Tesamorelin / Ipamorelin

Blend · Subcutaneous Refrigerate after reconstitution (2-8°C). Shelf life ≈ 60 days if kept sterile. 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 75.00 $ 75.00

Format
⚗ blend
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Visceral fat reduction, body composition improvement, growth hormone release, muscle development

La mezcla Tesamorelin/Ipamorelin combina un análogo GHRH con un GHRP para una potente liberación de la hormona del crecimiento, lo que favorece la reducción de la grasa visceral, la mejora de la composición corporal y el desarrollo muscular.

Clinical Indications
GH-axis optimization protocolsRecovery and lean-mass support plansSleep-linked anabolic pathway support
Recommended Stacking Protocols
✓
AOD-9604
Accelerates fat mobilization and lipolysis
✓
CJC-1295 (no DAC)
Enhances pulsatile GH release and sleep recovery
✓
5-Amino-1MQ / L-Carnitine
Supports metabolic efficiency and energy production
✓
BPC-157 / TB-500
Promotes muscle, joint, and tendon repair
Blend Components
Component Amount (mg)
Tesamorelin 10
Ipamorelin 5

Mechanism of Action - Growth Hormone Peptides Pathway

Targeted Signaling
Supports protocol objectives for Tesamorelin / Ipamorelin.
Clinical Modulation
Allows dose and schedule adjustments by response.
Outcome Tracking
Pairs with clinician monitoring for iterative optimization.
Starting Dose
Low initial dose
Initiation phase for tolerance and baseline response.
Titration
Escalate by protocol
Maintenance Range
Maintain physician-directed target
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Momento:Inyectar 30 minutos antes de dormir o al despertar en ayunas.

Almacenamiento:Refrigerar después de la reconstitución (2-8°C). Vida útil ≈ 60 días si se mantiene estéril.

Period Dose Phase Clinical Notes
Weeks 1-2 Initial phase initiation Begin conservatively and monitor tolerance.
Weeks 3-6 Escalation phase escalation Increase per protocol if tolerated.
Week 7+ Maintenance phase maintenance Maintain target dose and reassess monthly.
Preparation Protocol
  1. Utilice una jeringa de insulina de 1 ml (100 unidades = 1 ml).
  2. Evite los alimentos durante al menos 60 minutos después de la inyección para lograr una liberación máxima de GH.
  3. Refrigerar después de la reconstitución (2-8°C).
1
Inspect vial
Confirm vial integrity, lot, and expiration before use.
2
Aseptic reconstitution
Disinfect stopper and add bacteriostatic water slowly.
3
Gentle dissolution
Swirl gently until the solution is clear and homogeneous.
4
Prepare dose
Draw dose according to reconstitution conversion guidance.
Reconstitution & Dosing Guide

No reconstitution guide available for this strength.

Identity
  • Product Name: Tesamorelin / Ipamorelin
  • Product Type: Blend | Subcutaneous Injection
  • Strength Options: 10/5 mg
  • Components: Tesamorelin + Ipamorelin
Quality & Purity
  • Purity: >= 99%
  • Sterility: Aseptic handling required
  • Purity: 99%+
Storage & Handling
  • Storage: 2-8 C refrigerated
  • Handling: Avoid heat, shaking, and direct light
  • Storage: Refrigerate after reconstitution (2-8°C). Shelf life ≈ 60 days.

Timing: Inject 30 minutes before sleep or upon waking fasted. Avoid food for at least 60 minutes post-injection.

Storage: Refrigerate after reconstitution (2-8°C). Shelf life ≈ 60 days if kept sterile.

Frequency: Frequency:1xnightly (pre-bed)onempty stomach. Frequency:1xdaily（pre-bed)or2xdaily(AM+PM)forbodyrecomposition. Frequency:1nightly(pre-bed)foroptimizedGHpulse.

Cycle: Cycle:8-12weeksthen2-4weekbreak. .Cycle:10-16weeks. .Cycle:12weeksorcontinuouslow-dosemaintenance.

Injection Sites: Rotate approved injection sites to reduce local irritation risk.